BackInnate Pharma Overview

Innate Pharma Profit Margin

Profitability ratio analysis for IPHA.

Quarterly Profit Margin

-2494.00%
↑ 72.14% YoY

As of Dec 2025

Annual Profit Margin (TTM)

-693.12%
↓ 1838.67% YoY

Trailing 12 months ending Dec 2025

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin